{"id":"W1938050263","doi":"10.1200/jco.2014.32.4_suppl.lba1","title":"Enzalutamide in men with chemotherapy-naive metastatic prostate cancer (mCRPC): Results of phase III PREVAIL study.","year":2014,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":74,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta; Princess Margaret Cancer Centre","funders":"","keywords":"Enzalutamide; Medicine; Interim analysis; Placebo; Clinical endpoint; Hazard ratio; Internal medicine; Prostate cancer; Population; Docetaxel; Asymptomatic; Oncology; Cancer; Randomized controlled trial; Gastroenterology; Urology; Confidence interval; Androgen receptor; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005729652,0.0001673666,0.001878307,0.0002133004,0.00002455427,0.000006471186,0.0001693768,0.0001192952,0.00008555015],"category_scores_gemma":[0.00125301,0.00009291288,0.0001985527,0.0002838966,0.0003081977,0.0001108683,0.00003599513,0.0008135616,0.000003025019],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002301541,"about_ca_system_score_gemma":0.002150732,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002463388,"about_ca_topic_score_gemma":0.0002836124,"domain_scores_codex":[0.9956191,0.0007861598,0.002459592,0.0002500508,0.000579494,0.000305661],"domain_scores_gemma":[0.995404,0.001684745,0.001785427,0.0002360589,0.0005813568,0.0003084357],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.3197783,0.0232868,0.1856965,0.0001836709,0.002868349,0.001591115,0.004939748,0.0001086614,0.0009906774,0.00001912634,0.004423451,0.4561136],"study_design_scores_gemma":[0.5226707,0.1907995,0.2473777,0.0008586909,0.001443786,0.0001522781,0.002752407,0.0006940779,0.002761517,0.0003929652,0.02983752,0.0002589192],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9887875,0.000730821,0.00002376519,0.006306459,0.0001512835,0.001025719,0.00001264759,0.000005434481,0.002956361],"genre_scores_gemma":[0.9943349,0.002132819,0.0009278979,0.0004609541,0.0002897961,0.00003295791,0.000003514532,0.00002196099,0.001795225],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4558547,"threshold_uncertainty_score":0.3815306,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1163475950626397,"score_gpt":0.5176789045011821,"score_spread":0.4013313094385424,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}